This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,939.62 fixed-price delivery order is for the Arthrex ACP Double Syringe System, which will be delivered by November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with the DLA that allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. This contract award was not designated as a set-aside.
Generated 2/18/25, 1:43 PM